IMPACT BIOMEDICAL INC.
For the period ended Dec 31, 2025. Filed Mar 11, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 11, 2026
IBO$4.33+5.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Financial Statements
IMPACT BIOMEDICAL INC
TABLE OF CONTENTS
| Page | |
|---|---|
| Report of Independent Registered Public Accounting Firm (PCAOB ID: 606) | 26 |
| Consolidated Financial Statements: | |
| Consolidated Balance Sheets | 28 |
| Consolidated Statements of Operations | 29 |
| Consolidated Statements of Cash Flows | 30 |
| Consolidated Statements of Changes in Stockholders’ Equity | 31 |
| Notes to the Consolidated Financial Statements | 32 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.